BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7768247)

  • 1. Patient compliance and therapeutic coverage: comparison of amlodipine and slow release nifedipine in the treatment of hypertension. The Belgian Collaborative Study Group.
    Detry JM; Block P; De Backer G; Degaute JP
    Eur J Clin Pharmacol; 1995; 47(6):477-81. PubMed ID: 7768247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient compliance and therapeutic coverage: amlodipine versus nifedipine (slow-release) in the treatment of angina pectoris. Belgian Collaborative Group.
    Detry JM; Block P; De Backer G; Degaute JP; Six R
    J Int Med Res; 1994; 22(5):278-86. PubMed ID: 7867873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient compliance and therapeutic coverage: amlodipine versus nifedipine SR in the treatment of hypertension and angina: interim results. Steering Committee and Cardiologists and General Practitioners involved in the Belgium Multicentre Study on Patient Compliance.
    Detry JM
    Clin Cardiol; 1994 Sep; 17(9 Suppl 3):III12-6. PubMed ID: 9156955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release.
    Mounier-Vehier C; Bernaud C; Carré A; Lequeuche B; Hotton JM; Charpentier JC
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):478-86. PubMed ID: 9607387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of amlodipine dosing for conversion of nifedipine extended-release to amlodipine in the treatment of hypertension.
    Yamreudeewong W; Halverson VJ; Lower DL; Kilpatrick DM; Enlow AM; Montopoli G
    Ann Pharmacother; 1999 Jan; 33(1):7-10. PubMed ID: 9972377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ambulatory blood pressure-lowering effects of higher doses of different calcium antagonists in uncontrolled hypertension: the Calcium Antagonist Controlled-Release High-Dose Therapy in Uncontrolled Refractory Hypertensive Patients (CARILLON) Study.
    Mizuno H; Hoshide S; Tomitani N; Kario K
    Blood Press; 2017 Oct; 26(5):284-293. PubMed ID: 28524699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring.
    Leenen FH; Wilson TW; Bolli P; Larochelle P; Myers M; Handa SP; Boileau G; Tanner J
    Can J Cardiol; 1997 Oct; 13(10):914-20. PubMed ID: 9374947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients.
    Venkat-Raman G; Feehally J; Elliott HL; Griffin P; Moore RJ; Olubodun JO; Wilkinson R
    Nephrol Dial Transplant; 1998 Oct; 13(10):2612-6. PubMed ID: 9794569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Side effects of dihydropyridine therapy: comparison of amlodipine and nifedipine retard.
    Hosie J; Bremner AD; Fell PJ; James GV; Saul PA; Taylor SH
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S9-12. PubMed ID: 7522287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of drugs with more than a twenty-four-hour duration of action.
    Waeber B; Erne P; Saxenhofer H; Heynen G
    J Hypertens Suppl; 1994 Nov; 12(8):S67-71. PubMed ID: 7707159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early side-effects of antihypertensive therapy: comparison of amlodipine and nifedipine retard.
    Bremner AD; Fell PJ; Hosie J; James IG; Saul PA; Taylor SH
    J Hum Hypertens; 1993 Feb; 7(1):79-81. PubMed ID: 8450526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-acting calcium channel antagonists on neurohumoral factors: comparison of nifedipine coat-core with amlodipine.
    Tsutamoto T; Tsutsui T; Maeda K; Hayashi M; Wada A; Ohnishi M; Fujii M; Ishii C
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S77-81. PubMed ID: 12688402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of amlodipine and nifedipine retard in the treatment of mild to moderate hypertension.
    Lorimer AR; Anderson JA; Laher MS; Davies J; Lazarus JH; Taylor SH; Sanghera S
    J Hum Hypertens; 1994 Jan; 8(1):65-8. PubMed ID: 8151609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of amlodipine and the nifedipine retard preparation in the treatment of arterial hypertension].
    Pivac N; Dobovisek J; Bagatin J; Gros Furek V; Rumboldt Z; Janezić A; Kveder R; Sjerobabski V; Simunić M; Sardelić S
    Lijec Vjesn; 1993; 115(11-12):356-9. PubMed ID: 8176999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind comparison between nifedipine and amlodipine for the treatment of essential hypertension.
    Cappuccio FP; Markandu ND; Singer DR; Crane M; Carney C; MacGregor GA
    J Hum Hypertens; 1993 Aug; 7(4):365-8. PubMed ID: 8410927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension.
    Kalina Z; Okopień B; Madej A; Tokarz D; Maślankiewicz A; Szwed Z; Gross-Furek V; Herman ZS
    Boll Chim Farm; 1998; 137(7):281-5. PubMed ID: 9795483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparison between amlodipine and nifedipine retard in patients with essential arterial hypertension].
    Terrachini V; Canale C; Lonati A; Masperone MA; Bruzzone F; Malvestiti FM; Caponnetto S
    Clin Ter; 1992 Apr; 140(4):383-9. PubMed ID: 1534044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Time of drug intake in hypertension and angina pectoris. A controlled monitoring study].
    Erne P; Saxenhofer H; Waeber B; Heynen G
    Schweiz Rundsch Med Prax; 1994 Sep; 83(39):1079-83. PubMed ID: 7939074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.